Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands:A systematic review
BACKGROUND: Type 2 diabetes mellitus (T2DM) is an established risk factor for cardiovascular and nephropathic events. In the Netherlands, prevalence of T2DM is expected to be as high as 8% by 2025. This will result in significant clinical and economic impact, highlighting the need for well-informed reimbursement decisions for new treatments. However, availability and consistent use of costing methodologies is limited. OBJECTIVE: We aimed to systematically review recent costing data for T2DM-related cardiovascular and nephropathic events in the Netherlands. METHODS: A systematic literature revi... Mehr ...
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2019 |
| Reihe/Periodikum: | van Schoonhoven , A V , Gout-Zwart , J J , de Vries , M J S , van Asselt , A D I , Dvortsin , E , Vemer , P , van Boven , J F M & Postma , M J 2019 , ' Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands : A systematic review ' , PLoS ONE , vol. 14 , no. 9 , e0221856 . https://doi.org/10.1371/journal.pone.0221856 |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-26824453 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://hdl.handle.net/11370/0ab8c58f-43e3-41e0-be5b-a5387d39e39c |
